Arcadia Biosciences Inc. (NASDAQ:RKDA) traded today at a new 52-week low of $2.27. So far today approximately 1.9 million shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares.
There is potential upside of 163.0% for shares of Arcadia Biosciences Inc. based on a current price of $2.31 and an average consensus analyst price target of $6.08.
Arcadia Biosciences Inc is an agricultural biotechnology trait company. The company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. Geographically, it operates from in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.
Over the past year, Arcadia Biosciences Inc. has traded in a range of $2.27 to $6.40 and is now at $2.31.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer